Cell death: A trigger of autoimmunity?

BioEssays

Volumn 22, Issue 7, 2000, Pages 627-636

  Rodenburg, R J T ^a   Raats, J M H ^a   Pruijn, G J M ^a   Van Venrooij, Walther J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; RIBONUCLEOPROTEIN;

ANIMAL; APOPTOSIS; AUTOIMMUNITY; BIOLOGICAL MODEL; CELL DEATH; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMALS; APOPTOSIS; AUTOANTIGENS; AUTOIMMUNITY; BASE SEQUENCE; CELL DEATH; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS;

EID: 0033946640     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-1878(200007)22:7<627::AID-BIES5>3.0.CO;2-K     Document Type: Review

References (81)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44: 93-151.
2. Van Venrooij WJ, Maini RN. Manual of biological markers of disease. Dordrecht: Kluwer Academic Publishers 1996.
3. Shoenfeld Y, Isenberg D. The mosaic of autoimmunity. Oxford: Elsevier Science Ltd. 1989.
4. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 1992;356:314-317.
5. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
6. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells Nature 1995;376:181-184.
7. Theofilopoulos AN, Kofler R, Singer PA, Dixon FJ. Molecular genetics of murine lupus models. Adv Immunol 1989;46:61-109.
8. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis the autoimmune lymphoproliferative syndrome. Ann Int Med 1999;130:591-596.
9. Wang J, Zheng L, Lobito A, Chan FK-M, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999;98:47-58.
10. Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999;6:6-8.
11. Stennicke HR, Salvesen GS. Propertes of the caspases. Biochim Biophys Acta 1998;1387:17-31.
12. Porter AG, Ng P, Janicke RU. Death substrates came alive. Bioessays 1997;19:501-507.
13. Stroh C, Schulze-Osthoff K. Death by a thousand cuts: an ever increasing list of caspase substrates. Cell Death Differ 1998;5: 997-1000.
14. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 1996;183:1957-1964.
15. Klein Gunnewiek JMT, van de Pulte LBA, van Venrooij WJ. The U1 snRNP complex: an autoantigen in connective tissue diseases. Clin Exp Rheumatol 1997;15:549-560.
16. Utz PJ, Anderson P. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum 1998;41: 1152-1160.
17. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y. Identification of χ-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997;276:604-607.
18. Clemens MJ, Bushell M, Morley SJ. Degradation of eukaryotic polypeptide chain initiation factor (elF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 1998;17:2921-2931.
19. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995; 377:446-448.
20. Andrade F, Roy S, Nicholson D, Thornberry N, Rosen A, Casciola-Rosen L. Granzyme B directly and evidently cleaves several downstream caspase substrates: implications for CTL-incuced apoptosis. Immunity 1998;8:451-460.
21. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999;190:815-826.
22. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997;91:443-446.
23. Casiano CA, Ochs RL, Tan EM. Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes. Cell Death Differ 1998;5:183-190.
24. Santoro MF, Annand RR, Robertson MM, Peng YW, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW, Giege DA. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 1998;273:13119-13128.
25. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody oroduction in patients with systemic lupus erythematosus. J Exp Med 1997;5:843-854.
26. Utz PJ, Hottelet M, van Venrooij WJ, Anderson P. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accomoanies apoptotic cell death. J Exp Med 1998;187:547-560.
27. Stetler DA, Jacob ST. Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus patients. J Biol Chem 1984;259:13629-13632.
28. Satoh M, Ajmani AK, Ogasawara T, Langdon JJ, Hirakata M, Wang J, Reeves WH. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome Specific recognition of the phosphorylated (IIO) form by a subset of human sera. J Clin Invest 1994;94:1981-1989.
29. Rutjes SA, Utz PJ, van der Heiden A, Broekhuis C, van Venrooij WJ, Pruijn GJM. The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved during apoptosis. Cell Death Differ 1999;6:976-986.
30. Asaga H, Yamada M, Senshu T. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 1998;243:641-646.
31. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthrit s-specific autoantibodies. J Clin Invest 1998; 101:273-281.
32. Girbal-Neuhauser E, Duneux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet-Reynaud C, Jolivet M, Serre G. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)'ilaggrin by deimination of arginine residues. J Immunol 1999;162:585-594.
33. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 1998;273:13703-13712.
34. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;393:396.
35. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391: 96-99.
36. Crawford DR, Lauzon RJ, Wang Y, Mazurkiewicz JE, Schools GP, Davies KJ. 16S mitochondrial ribosomal RNA degradation is associated with apoptosis. Free Radic Biol Med 1997;22:1295-1300.
37. Houge G, Doskeland SO, Boe R, Lanotte M. Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis FEBS Lett 1993;315:16-20.
38. Degen WGJ, van Aarssen Y, Pruijn GJM, Utz PJ, van Venrooij WJ. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule. Cell Death Differ 2000;7:70-80.
39. van Venrooij WJ, Hoet R, Castrop J, Hageman B, Mattaj IW, van de Putte LBA. Anti-(UI) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases. J Clin Invest 1990;86:2154-2160.
40. Rutjes SA, van der Heijden A, Utz PJ, van Venrooij WJ, Pruijn GJM. Rapid nucleolytic degradation of the small cytoplasmic Y RNAs during apoptosis. J Biol Chem 1999;274:24799-24807.
41. Pruijn GJM, Slobbe RL, van Venrooij WJ. Analysis of protein-RNA interactions within Ro ribonucleoprotein complexes. Nucleic Acids Res 1991;19:5173-5180.
42. Boulanger C, Chabot B, Menard H-A, Boire G. Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clin Exp Immunol 1995;99:29-36.
43. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoanlibody-inducing T cells of lupus. J Exp Med 1993;177:1367-1381.
44. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of pnosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-2216.
45. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997;158:4525-4528.
46. Price BE, Rauch J, Shia MA, Walsh MT, Lieberthal W, Gilligan HM, O'Laughlin T, Koh JS, Levine JS. Antiphospholipid autoantibodies bind to apoptotic, but not nonapoptotic, thymocytes in a β2-glycoprotein dependent manner. J Immunol 1996;157:2201-2208.
47. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84: 1415-1420.
48. Matsuda J, Satoh N, Gohchi K, Gotoh M, Yamamoto T. Anti-annexin V antibody n systemic lupus erythematosus patients with lupus anticoagulant and/or anticardioipin antibody. Am J Hematol 1994;47: 56-58.
49. Wener MH, Uwatoko S, Mannik M. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 1989;32:544-551.
50. LeFeber WP, Norris DA, Ryan SR, Huff JC, Lee LA, Kubo M, Boyce ST, Kotzin BL, Weston WL. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984;74:1545-1551.
51. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179: 1317-1330.
52. Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P, Rugarli C, Manfredi AA. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol 1998;161:4467-4471.
53. Rovere P, Sabbadini MG, Vallinoto C, Fascio U, Zimmerman VS, Bondanza A, Ricciardi-Castagnoli P, Manfredi AA. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J Leukoc Biol 1999;66:345-349.
54. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392: 86-89.
55. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
56. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994;152:1453-1461.
57. Fatenejad S, Mamula MJ, Craft J. Role of intermolecular/intrastructural B-and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci USA 1993;90: 12010-12014.
58. James JA, Gross T, Scofield H, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/ B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-461.
59. Devitt A, Moffalt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392:505-509.
60. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343:170-173.
61. Luciani MF, Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 1996;15:226-235.
62. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci USA 1996;93: 12456-12460.
63. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K. SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996;222:246-250.
64. Mevorach D, Mascarennas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998;188:2313-2320.
65. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998;101:890-898.
66. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Irrmunosuppressive effects of apoptotic cells. Nature 1997;390:350-351.
67. Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti MP, Davoust J, Rugarli C, Manfredi AA. Processing of engulfed apoptotic bodies yields T celi epitopes. J Immunol 1997;159:5391-5399.
68. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D, Albert M, Bhardwaj N, Mellman I, Steinman RM. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998;188:2163-2173.
69. Bickerstaff MCM, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJG, Walport MJ, Pepys MB. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 1999;5:694-697.
70. Cohen PL, Eisenberg RA. Ipr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 1991;9: 243-269.
71. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Med 1998;19:56-59.
72. Mevorach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387-392.
73. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat Cell Biol 1999;1:227-233.
74. Erwig LP, Kluth DC, Walsh GM, Rees AJ. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J Immunol 1998;161:1983-1988.
75. Liu Y, Cousin JM, Hughes J, van Damme J, Seckl JR, Haslett C, Dransfield I, Savill J, Rossi AG. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999;162:3639-3646.
76. Schlegel RA, Krahling S, Callahan MK, Williamson P. CD14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes. Cell Death Differ 1999;6:583-592.
77. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res 1999;20:67-78.
78. InSug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicology 1997;124:211-224.
79. Akahoshi T, Namai R, Sekiyama N, Tanaka S, Hosaka S, Kondo H. Rapid induction of neutrophil apoptosis by sulfasalazine: implications of reactive oxygen species in the apoptotic process. J Leukocyte Biol 1997;62:817-826.
80. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulant events and antigenic spread in systemic luous erythematosus. Proc Natl Acad Sci USA 1996;93:1624-1629.
81. Casciola-Rosen L, Wigley F, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997;185:71-79.